SCHEMBL1470239

SCHEMBL1470239

CC(C)S(=O)(=O)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2148543 0.78 TSHR (0.33)
SCHEMBL28396423 0.75
SCHEMBL11392993 0.75
SCHEMBL11116364 0.75
SCHEMBL21423111 0.70
SCHEMBL349157 0.70
Isopropylamine SCHEMBL28353117 0.70
SCHEMBL14118803 0.70 TSHR (0.33)
SCHEMBL4412627 0.68
SCHEMBL1470242 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119019295-B Preparation method of N, N-dimethyl trifluoro methanesulfonamide 江苏国泰超威新材料有限公司 2025-04-29 CN claimed
US-20210159541-A1 ELECTROLYTE FOR LITHIUM BATTERY AND LITHIUM BATTERY COMPRISING SAME SAMSUNG SDI CO., LTD. (KR) 2021-05-27 US claimed
CN-110870126-A Electrolyte for lithium battery and lithium battery including the same 三星SDI株式会社 2020-03-06 CN claimed
US-9136560-B2 Nonaqueous electrolyte solution and lithium secondary battery using same MITSUBISHI CHEMICAL CORPORATION (JP) 2015-09-15 US claimed
EP-0921790-A4 SULFONYL FLUORIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE UNIV TEXAS (US) 2000-11-02 EP claimed
EP-0921790-A1 SULFONYL FLUORIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE The Board of Regents, The University of Texas System (US) 1999-06-16 EP claimed
US-5798392-A IRREVERSIBLE ACETYLCHOLINESTERASE INHIBITORS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 1998-08-25 US claimed
WO-1998008497-A1 SULFONYL FLUORIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 1998-03-05 WO claimed
WO-2026088635-A1 BIFUNCTIONAL COMPOUND COMPRISING BRANCHED PERFLUOROALKYL GROUP AND METHOD FOR PRODUCING DERIVATIVE THEREOF 三菱マテリアル電子化成株式会社 2026-04-30 WO disclosed
EP-3351548-B1 CROSSLINKED NUCLEIC ACID GUNA, METHOD FOR PRODUCING SAME, AND INTERMEDIATE COMPOUND MITSUBISHI TANABE PHARMA CORP (JP) 2025-08-20 EP disclosed
CN-112470320-B Nonaqueous electrolyte for battery and lithium secondary battery 三井化学株式会社 2024-12-27 CN disclosed
US-12095037-B2 Non-aqueous electrolyte solution for battery and lithium secondary battery MITSUI CHEMICALS, INC. (JP) 2024-09-17 US disclosed
CN-118412540-A Nonaqueous electrolyte for battery and lithium secondary battery 三井化学株式会社 2024-07-30 CN disclosed
US-20240226113-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF KUMQUAT BIOSCIENCES INC. 2024-07-11 US disclosed
US-6063734-A AGRICULTURAL CHEMICALS, AGENTS FOR PREVENTING ATTACHMENT OF AQUATIC ORGANISMS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2000-05-16 US disclosed
EP-0921790-A1 SULFONYL FLUORIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE The Board of Regents, The University of Texas System (US) 1999-06-16 EP disclosed
EP-0913392-A1 ETHYLENE DERIVATIVES AND PEST CONTROLLING AGENTS NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1999-05-06 EP disclosed
US-5798392-A IRREVERSIBLE ACETYLCHOLINESTERASE INHIBITORS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 1998-08-25 US disclosed
WO-1998008497-A1 SULFONYL FLUORIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 1998-03-05 WO disclosed
US-4992456-A Plant protection BAYER AKTIENGESELLSCHAFT (DE) 1991-02-12 US disclosed